Everest Medicines Announces Interim Results for First Half of 2024 [Yahoo! Finance]
Calliditas Therapeutics AB - American Depositary Shares (CALT)
Company Research
Source: Yahoo! Finance
development, manufacturing and commercialization of innovative medicines and vaccines, today announced its interim results for the first half of 2024 along with a corporate update. "Our total revenue for the first half of 2024 reached RMB 301.5 million , a significant growth of 158% compared to the second half of 2023, while operating expenses as a percentage of revenue[1] declined by 249%, reflecting significant improvement on operating efficiency," commented Rogers Yongqing Luo, CEO of Everest Medicines. "Notably, our non-IFRS loss narrowed by 35%, and our gross margin excluding non-cash items was 83%. For the first time in Company history, we have achieved commercial level profitability[2]. Our cash balance of RMB1.93 billion remains strong and provides significant flexibility to fund the continued growth of our business. In the first half of 2024, we accomplished multiple commercialization milestones. NEFECON ® , our lead product in the renal portfolio and the first-in-disease t
Show less
Read more
Impact Snapshot
Event Time:
CALT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CALT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CALT alerts
High impacting Calliditas Therapeutics AB - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
CALT
News
- Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm [Yahoo! Finance]Yahoo! Finance
- Delisting of Calliditas Therapeutics AB (publ) from Nasdaq StockholmPR Newswire
- 3 Swedish Growth Stocks With Up To 35% Insider Ownership [Yahoo! Finance]Yahoo! Finance
- 3 Swedish Growth Stocks With High Insider Ownership [Yahoo! Finance]Yahoo! Finance
- Top Growth Companies With High Insider Ownership [Yahoo! Finance]Yahoo! Finance
CALT
Sec Filings
- 9/23/24 - Form SC
- 9/20/24 - Form 25-NSE
- 9/18/24 - Form SC
- CALT's page on the SEC website